The acquisition sees Inflection's co-founders transitioning to Microsoft, leaving the startup under new leadership to salvage the ambitious project.
However, a recent report suggests that many microbiome companies may be operating with more enthusiasm than scientific rigor, raising concerns about the lack of meaningful regulation.
Collection
[
|
...
]